-
An outbreak of hepatitis C virus (HCV) that recently sparked a massive testing effort affecting 40,000 patients in Las Vegas comes as the largest, latest "look-back" in a series of ambulatory care exposures that shows no signs of stopping.
-
Appropriately enough in Las Vegas, the largest patient look-back investigation in history will come down to something akin to a high-stakes bingo game.
-
In response to a hepatitis C virus outbreak in an endoscopy center in Las Vegas, the American Association of Nurse Anesthetists (AANA) in Park Ridge, IL, is reiterating safe needle practices to all of its members.
-
In light of an outbreak of hepatitis C virus that resulted in public health officials advising 40,000 patients to be tested, Dipak Desai, MD, majority owner of the Endoscopy Center of Southern Nevada at 700 Shadow Lane, issued the following statement on March 10, 2008:
-
This multicenter, randomized, double-blind, placebo-controlled trial of hydrocortisone replacement in septic shock aimed to evaluate 28-day mortality in non-responders to corticotropin stimulation.
-
Trauma surgeons at the Regional Medical Center at Memphis carried out a randomized clinical trial comparing a continuous ethanol infusion with a protocol of scheduled diazepam administration for the prevention and control of severe alcohol withdrawal syndrome (AWS) among patients admitted to their ICU following trauma.
-
It is now well established that ventilating patients with acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) using a strategy that limits alveolar distending volume and end-inspiratory static airway pressure results in improved survival, as compared to larger-volume, higher-pressure ventilation.
-
-
This multicenter randomized trialnicknamed the VISEP studyused a two-by-two factorial design to test two independent treatments in severe sepsis patients.
-
In this issue: Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
